Focus on Vastarel MR Effects of Vastarel MR on brain natriuretic peptide and cardiac troponin concentrations
نویسنده
چکیده
Metabolic therapy represents an innovative approach to the treatment of coronary artery disease and heart failure. The metabolic modulator, trimetazidine (Vastarel MR), offers particular positive effects in reducing the cell loss and reorganization that characterize the process of left ventricle remodeling, and is useful in improving ischemic or failed cell metabolism. Correction of the metabolic alterations that characterize ischemic cardiomyopathy and heart failure represents a promising novel therapeutic approach useful in reducing left ventricle remodeling and improving the prognosis of patients suffering these conditions. Heart Metab. 2009;43:23–26.
منابع مشابه
Focus on Vastarel MR Beneficial long-term effects of Vastarel MR in patients with stable coronary artery disease developing left ventricular dysfunction
During the past two decades, the management of chronic coronary artery diseases has improved considerably, as a result of both pharmacotherapy and revascularization procedures. However, the course of chronic coronary artery disease, with an increase in the number of patients surviving after acute coronary syndrome, has led to an increase in the number of patients with ischemic left ventricular ...
متن کاملFocus on Vastarel MR Reperfusion injury: reduction by Vastarel MR
Ischemia-reperfusion syndrome is defined as myocardial injury caused by the restoration of coronary flow. This phenomenon has a complex pathophysiology and results in a paradoxical reduction of the beneficial effect of myocardial reperfusion. Studies suggest that ischemia-reperfusion injury may account for up to 50% of the final size of a myocardial infarct. Vastarel MR (trimetazidine) is a pha...
متن کاملVastarel MR: from decades of clinical experience in stable angina to new perspectives
Trimetazidine has been known for years as being an effective, ‘‘patient-friendly’’, anti-anginal agent. Recent studies using the modified release formulation (Vastarel MR) have confirmed the efficacy of trimetazidine in stable ischemic heart disease and suggested that it can be beneficial in a number of
متن کاملFocus on Vastarel MR Clinical benefits of a metabolic approach in the treatment of ischemic heart disease: focus on Vastarel MR
Despite the recent decline in cardiovascular mortality, Ischemic Heart Disease (IHD) remains the leading single cause of death in the western world. Great hopes were provoked by the introduction of surgical and percutaneous myocardial revascularization techniques that promised to be a safe and effective alternative to control symptoms and to improve prognosis in these patients. Unfortunately, c...
متن کاملEvaluation of cardiac troponin I, atrial natriuretic peptide and some oxidative/antioxidative biomarkers in the serum and hemolysate of trained Arabian horses after exercise
Background: Limited information existed on performance tests in Iranian Arab horses. Aims: The objective of this study is to investigate time related changes of cardiac troponin I (cTnI), atrial natriuretic peptide (ANP) and oxidative/antioxidant biomarkers in the serum of Arabian horses before and after regular training. Methods: Blood samples were collected from jugular vein of 25 Arabian hor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009